Chloroplasts as expression platforms for plant-produced vaccines.

Area of Science:

• Biotechnology
• Molecular Biology
• Vaccinology

Background:

• Recombinant subunit vaccines offer a safer alternative to traditional vaccines.
• Achieving high expression levels and effective biocontainment are key challenges in vaccine production.

Purpose of the Study:

• To highlight the advantages of using the plastid genome for producing recombinant vaccine antigens.
• To discuss the core technology of plastid transformation in model organisms.
• To demonstrate the utility of this approach for vaccine development.

Main Methods:

• Plastid transformation in Chlamydomonas reinhardtii (unicellular alga) and Nicotiana tabacum (tobacco).
• Leveraging high transgene copy number for enhanced expression.
• Utilizing maternal inheritance for biocontainment and pollen-free transgene transmission.

Main Results:

• High expression levels of recombinant proteins are achievable due to high transgene copy number.
• Maternal inheritance of plastids ensures biocontainment, preventing transgene spread.
• Expression of multiple transgenes is facilitated through prokaryotic-like operons.

Conclusions:

• Plastid genome engineering is a powerful platform for efficient and contained production of recombinant vaccine antigens.
• This technology holds significant promise for advancing vaccine development and manufacturing.